Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease

Haberman R, Herati R, Simon D, Samanovic M, Tuen M, Blank R, Koralov S, Atreya R, Tascilar K, Allen J, Castillo R, Cornelius A, Rackoff P, Solomon G, Adhikari S, Azar N, Rosenthal P, Izmirly P, Samuels J, Golden B, Reddy S, Neurath M, Abramson SB, Schett G, Mulligan M, Scher J (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 3205-3208

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

DOI: 10.1101/2021.05.11.21256917

Authors with CRIS profile

David Simon Department of Medicine 3 – Rheumatology and Immunology Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur) Koray Tascilar Department of Medicine 3 – Rheumatology and Immunology Markus Neurath Lehrstuhl für Innere Medizin I Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

New York University (NYU) US United States (USA) (US) NYU Langone Medical Center US United States (USA) (US)

How to cite

APA:

Haberman, R., Herati, R., Simon, D., Samanovic, M., Tuen, M., Blank, R.,... Scher, J. (2021). Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease. In ARTHRITIS & RHEUMATOLOGY (pp. 3205-3208). HOBOKEN: WILEY.

MLA:

Haberman, Rebecca, et al. "Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2021. 3205-3208.

BibTeX: Download